My Affair with the Spike
Release time:
2022-04-06
■ Yunnan Jianfeng Shang Yongzhen
first came into contact with "Jianfeng Bao" after listening to the workshop director, not for anything else, just because my cultural level is OK, the director thinks this is a good opportunity to train me. When I first entered the workplace, I took over this task nervously and excitedly, because I knew very well that I was a liberal arts student who was not good at writing. About a week later, I sent the manuscript to the director with trepidation. I felt uneasy for fear that he would laugh at me. After that, I handed in one or two articles from time to time, sometimes scenery, sometimes characters, and sometimes pure complaints. Then one day, I found that there was my name on the newspaper. I was so excited that I found out the manuscript and read it countless times. Finally, I came to the conclusion that it was just a lucky one. After that, I also participated in the correspondent training organized by the group company, but only to complete the tasks arranged by the leaders.
Due to the successive transfer of jobs, I didn't pay special attention to writing articles and submitting articles. I started writing essays again to record my life after joining the marketing department for two years and my job was stable. Now I want to thank the members of the editorial department of "Jianfeng Bao" for their tolerance to me. No matter what they have written and how they have written for such a long time, they have taken it seriously. Sometimes it is the guidance comments forwarded by colleagues, sometimes it is the editor-in-chief who directly guides the revision. All of a sudden, I feel that my thinking of recording work and life with a pen has broadened a lot, and my confidence as a correspondent has also been continuously improved. Through continuous study and exploration, my articles appeared more and more frequently in the newspaper, which strengthened my determination as a correspondent.
Occasionally go back to look through the collection and think of many people and things that used to be. She recorded my continuous efforts and growth. More importantly, "Spike News" gave me courage. I used to dare not write, or write a casual record. Under her encouragement, I became more confident. Through the sharing of "peak newspaper", I know how to pay more attention to the people and things around me, and learn to cherish the happiness around me more. In 2020 , I was also very honored to publish a personal special edition. This honor, which I have always dreamed of, made me so excited that I didn't sleep soundly for several days. The feeling was even more exciting than when I passed the first line of the college entrance examination.
has entered the peak for ten years, and the leaders and colleagues around him have changed a lot, but the "peak newspaper" has always been there. it has been paying close attention to the people and things of the peak, recording every critical moment of the peak, cheering every progress of the peak cause, and carrying the infinite joy of the peak people. "Peak Newspaper" has gone through 30 spring and autumn. Let's go hand in hand and climb the peak together to help "Peak Newspaper" go further.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31